Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
• Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction